These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Angiopoietins/TIE2 system and VEGF are involved in ovarian function in a DHEA rat model of polycystic ovary syndrome. Abramovich D; Irusta G; Bas D; Cataldi NI; Parborell F; Tesone M Endocrinology; 2012 Jul; 153(7):3446-56. PubMed ID: 22577112 [TBL] [Abstract][Full Text] [Related]
26. Angiogenesis and microvasculature in the female reproductive organs: physiological and pathological implications. Shimizu T; Hoshino Y; Miyazaki H; Sato E Curr Pharm Des; 2012; 18(3):303-9. PubMed ID: 22229567 [TBL] [Abstract][Full Text] [Related]
27. Differential expression of the angiogenic factor genes vascular endothelial growth factor (VEGF) and endocrine gland-derived VEGF in normal and polycystic human ovaries. Ferrara N; Frantz G; LeCouter J; Dillard-Telm L; Pham T; Draksharapu A; Giordano T; Peale F Am J Pathol; 2003 Jun; 162(6):1881-93. PubMed ID: 12759245 [TBL] [Abstract][Full Text] [Related]
28. Angiogenesis in The Ovary - The Most Important Regulatory Event for Follicle and Corpus Luteum Development and Function in Cow - An Overview. Berisha B; Schams D; Rodler D; Pfaffl MW Anat Histol Embryol; 2016 Apr; 45(2):124-30. PubMed ID: 25951313 [TBL] [Abstract][Full Text] [Related]
29. Role of pigment epithelium-derived factor in the reproductive system. Chuderland D; Ben-Ami I; Bar-Joseph H; Shalgi R Reproduction; 2014 Oct; 148(4):R53-61. PubMed ID: 25049425 [TBL] [Abstract][Full Text] [Related]
30. Angiogenesis in ovarian cancer. Brown MR; Blanchette JO; Kohn EC Baillieres Best Pract Res Clin Obstet Gynaecol; 2000 Dec; 14(6):901-18. PubMed ID: 11141340 [TBL] [Abstract][Full Text] [Related]
31. Mice null for Frizzled4 (Fzd4-/-) are infertile and exhibit impaired corpora lutea formation and function. Hsieh M; Boerboom D; Shimada M; Lo Y; Parlow AF; Luhmann UF; Berger W; Richards JS Biol Reprod; 2005 Dec; 73(6):1135-46. PubMed ID: 16093361 [TBL] [Abstract][Full Text] [Related]
32. Suppression of luteal angiogenesis in the primate after neutralization of vascular endothelial growth factor. Fraser HM; Dickson SE; Lunn SF; Wulff C; Morris KD; Carroll VA; Bicknell R Endocrinology; 2000 Mar; 141(3):995-1000. PubMed ID: 10698175 [TBL] [Abstract][Full Text] [Related]
33. Angiogenesis in the female reproductive system. Augustin HG EXS; 2005; (94):35-52. PubMed ID: 15617469 [No Abstract] [Full Text] [Related]
34. Manipulation of ovarian follicle development by injecting vascular endothelial growth factor (VEGF) gene. Shimizu T; Sato E Reprod Biol; 2005 Nov; 5(3):257-68. PubMed ID: 16372043 [TBL] [Abstract][Full Text] [Related]
36. Angiogenesis and vascular endothelial growth factor expression in the equine corpus luteum. Al-zi'abi MO; Watson ED; Fraser HM Reproduction; 2003 Feb; 125(2):259-70. PubMed ID: 12578540 [TBL] [Abstract][Full Text] [Related]
37. Vascular endothelial growth factor localization in human ovary and fallopian tubes: possible role in reproductive function and ovarian cyst formation. Gordon JD; Mesiano S; Zaloudek CJ; Jaffe RB J Clin Endocrinol Metab; 1996 Jan; 81(1):353-9. PubMed ID: 8550777 [TBL] [Abstract][Full Text] [Related]